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 A Case Of Flecainide Overdose 
 
Abistanand Ankam MD, Stanlies D’Souza MD, Natalie Maida DO, Shanthan Sunku MD 
 
Department of Anesthesiology, Baystate Medical Center/ Tufts University School of Medicine, Springfield, MA 
CONCLUSION 
 
ECMO should be considered early in 
the management of severe flecainide 
toxicity with conduction disturbances 
and hemodynamic collapse along 
with other supportive measures.  
REFERENCES 
  
1. Cheung ITF, Man CY. Review on Flecainide Poisoning. Hong Kong Journal of Emergency Medicine 2002;9:150-3  
2. Moussot PE, Marhar F, Minville V, Vallé B, Dehours E, Bounes V, Ducassé JL.  Use of intravenous lipid 20% emulsion for the treatment of a voluntary intoxication of 
    flecainide with refractory shock. Clin Toxicol  2011;49:514 
3. Timperley J, Mitchell ARJ, Brown PD, West NEJ. Flecainide overdose--support using an intra-aortic balloon pump. BMC Emerg Med. 2005;5:10 
4. Auzinger GM, Scheinkestel CD. Successful extracorporeal life support in a case of severe flecainide intoxication. Crit Care Med 2001;29:887-90 
5. Baud FJ, Megarbane B, Deye N, Leprince P. Clinical review: Aggressive management and extracorporeal support for drug-induced cardiotoxicity.  
    Crit Care 2007;11:207 
DISCUSSION 
 
Flecainide toxicity is associated with 
10% mortality.1 Flecainide toxicity is 
associated with conduction 
abnormalities leading to pulseless 
electrical activity and asystole, severe 
hypotension secondary to myocardial 
depression, metabolic acidosis, 
hypoxia, convulsions and coma. 
Management of flecainide toxicity 
includes pharmacotherapy with 
activated charcoal within first hour 
after ingestion, inotropes and fluids 
for hypotension, seizure control with 
benzodiazepines, sodium bicarbonate 
to treat acidosis and maintain pH of 
7.5 - 7.55. Intralipid has been used as 
it acts as a “lipid sink” for lipid 
soluble drug overdoses.2 There are 
case reports of intra aortic balloon 
pump3, cardiopulmonary bypass and 
ECMO being used successfully in the 
management of flecainide toxicity.4,5 
ECMO improves hepatic perfusion 
and helps liver metabolize flecainide.  
CASE DESCRIPTION 
 
A 51 year old female with past medical 
history of atrial fibrillation and 
depression was found unresponsive, 
hypotensive and bradycardic following 
flecainide overdose. She was externally 
paced for wide QRS complexes and was 
successfully resuscitated according to 
ACLS protocol for pulseless electrical 
activity (PEA) cardiac arrest. The patient 
received activated charcoal, sodium 
bicarbonate and intralipid following the 
recommendations of the Poison Control 
Center. She required norepinephrine for 
hypotension and lorazepam for grand 
mal seizures. As flecainide is not 
dialyzable, patient received 
extracorporeal membrane oxygenation 
(ECMO) for 24 hours until hemodynamic 
stability with narrow QRS complexes 
and an intact neurological status was 
regained.  
INTRODUCTION 
 
Flecainide is a Vaughn-Williams class 
1C antiarrhythmic used for the treatment 
of supraventricular arrhythmias. Severe 
flecainide toxicity is associated with 
high mortality because of severe 
hypotension and ventricular 
arrhythmias. We present a case where 
severe flecainide toxicity is managed 
successfully using extracorporeal 
membrane oxygenation ( ECMO ). 
 
 
 
 
 
 
 
